Project: Reactive Oxygen Species (ROS) Activators to Treat the Rare disease Guillain-Barré Syndrome (GBS)

Acronym rosaGBS (Reference Number: 10082)
Duration 01/04/2016 - 01/10/2018
Project Topic We will establish a novel therapeutic treatment of the orphan paralysis condition Guillain-Barré Syndrome (GBS), to enable orphan drug designation, clinical development and out-licensing to a Pharma partner. The project will also validate new In Vitro tests notably on human pluripotent stem cell-derived neural tissues to analyse neurotoxicity and optimise methodology to improve the bioavailability of compounds with difficult administration properties by medicinal chemistry and formulation.
Network Eurostars 2
Call Eurostars Cut-Off 4

Project partner

Number Name Role Country
22811 RedGlead Discovery AB Partner Sweden
22812 Neurix SA Partner Switzerland
22813 ProNoxis AB Coordinator Sweden